Cyclic peptides extend the druggable target space due
to their
size, flexibility, and hydrogen-bonding capacity. However, these properties
impact also their passive membrane permeability. As the “journey”
through membranes cannot be monitored experimentally, little is known
about the underlying process, which hinders rational design. Here,
we use molecular simulations to uncover how cyclic peptides permeate
a membrane. We show that side chains can act as “molecular
anchors”, establishing the first contact with the membrane
and enabling insertion. Once inside, the peptides are positioned between
headgroups and lipid tailsa unique polar/apolar interface.
Only one of two distinct orientations at this interface allows for
the formation of the permeable “closed” conformation.
In the closed conformation, the peptide crosses to the lower leaflet
via another “anchoring” and flipping mechanism. Our
findings provide atomistic insights into the permeation process of
flexible cyclic peptides and reveal design considerations for each
step of the process.